"Our teriparatide drug product is bioequivalent and therapeutically equivalent to Eli Lilly's FORTEO®, providing patients confidence in its reliability and effectiveness, while offering a thoughtfully ...

In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide injection prefilled pen, deemed bioequivalent and therapeutically ...

for the treatment of postmenopausal women with osteoporosis at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy; to increase bone mass in men with ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...

Investing.com -- Amphastar Pharmaceuticals (NASDAQ:AMPH) stock gained 2.3% in Monday’s premarket trading after the company announced FDA approval of its teriparatide injection, a generic equivalent to ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...

Dear Dr. Roach: I am a 68-year-old female who was first diagnosed with osteopenia and now osteoporosis. My physician has highly recommended medication or a monthly injection. I have completed hours of ...

DEAR DR. ROACH: I am a 68-year-old female who was first diagnosed with osteopenia and now osteoporosis. My physician has highly recommended medication or a monthly injection. I have completed hours of ...